Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies

NCT00145613 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Secondary AML
Myelodysplastic Syndrome (MDS)
Secondary MDS
Chronic Myeloid Leukemia
Juvenile Myelomonocytic Leukemia (JMML)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Lymphoma, Non-Hodgkin
Hodgkin Disease

Interventions

PROCEDURE: Stem Cell Transplantation
DEVICE: Miltenyi Biotec CliniMACS
DRUG: Systemic chemotherapy and antibodies

Sponsor

St. Jude Children's Research Hospital